L827-0175 Screening compound: 5-(3-phenyl-1,2,4-oxadiazol-5-yl)-N-[3-(propan-2-yloxy)propyl]pyridin-2-amine

L827-0175 Screening compound: 5-(3-phenyl-1,2,4-oxadiazol-5-yl)-N-[3-(propan-2-yloxy)propyl]pyridin-2-amine
L827-0175 Screening compound: 5-(3-phenyl-1,2,4-oxadiazol-5-yl)-N-[3-(propan-2-yloxy)propyl]pyridin-2-amine alternative view

Chemical Structure Depiction of ChemDiv screening compound L827-0175
5-(3-phenyl-1,2,4-oxadiazol-5-yl)-N-[3-(propan-2-yloxy)propyl]pyridin-2-amine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

L827-0175

Molecular Formula

C19H22N4O2 (C19 H22 N4 O2)

Compound Name

5-(3-phenyl-1,2,4-oxadiazol-5-yl)-N-[3-(propan-2-yloxy)propyl]pyridin-2-amine

IUPAC name

5-(3-phenyl-124-oxadiazol-5-yl)-N-[3-(propan-2-yloxy)propyl]pyridin-2-amine

SMILES

CC(C)OCCCNc(cc1)ncc1-c1nc(-c2ccccc2)no1

InChI

InChI=1S/C19H22N4O2/c1-14(2)24-12-6-11-20-17-10-9-16(13-21-17)19-22-18(23-25-19)15-7-4-3-5-8-15/h3-5,7-10,13-14H,6,11-12H2,1-2H3,(H,20,21)

InChI Key

JZVZTENOVGMWDK-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD27478158

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

338.41

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

8.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.175

Distribution Coefficient, logD

4.166

Water Solubility, LogSw

-4.05

Polar Surface Area

58.897

Acid Dissociation Constant (pKa)

21.00

Base Dissociation Constant (pKb)

5.70

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

31.60

L827-0175 in Drug Discovery

Included in Screening Libraries

Anticancer Library (62698 compounds)

C-Met Library (15277 compounds)

Protein Kinases Inhibitors Library (36801 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Endocrine
  • Cancer
  • Digestive system
  • Respiratory tract
  • Otorhinolaryngologic
  • Nervous system
  • Hemic and lymphatic
  • Cardiovascular
Targets:
  • Kinases
  • Kinases
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with L827-0175 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound L827-0175?
Check Price and Availability of L827-0175, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of L827-0175 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for L827-0175
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for L827-0175
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of L827-0175 available by request